Dossier · Scrutiny of an implementing measure

Commission Regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products

Reference: 2026/2838(RPS) Scrutiny of an implementing measure
Where it stands: Parliament adopted the objection on 16 September 2026 — the Commission measure is blocked.
Stage: Parliament’s position
Lead committee: Environment, Climate and Food Safety ENVI

More facts (4)

Authors: Christophe CLERGEAU, Martin HOJSÍK, Jutta PAULUS, Anja HAZEKAMP
Decisions in plenary: 1
Last vote: 16 Sept 2026 · Objection passed
Versions: 1 version

Authors: Christophe CLERGEAU, Martin HOJSÍK, Jutta PAULUS, Anja HAZEKAMP
Decisions in plenary: 1
Last vote: 16 Sept 2026 · Objection passed
Versions: 1 version

Cite this page

Legislative Observatory

Link to this page

Where it stands

The steps of this kind of dossier and how far it has come, from the procedure file.

Referred to committee (done) 16 September 2026
Committee work (done)
Tabled for plenary (done)
Plenary vote (done) Adopted 16 September 2026
Parliament’s position (done) Final

The Commission adopted an implementing measure. Parliament can object; an adopted objection stops the measure.

People

Committees and members responsible for the dossier, as the procedure file names them. Groups as recorded there.

Lead committee: Environment, Climate and Food Safety ENVI
Authors: Christophe CLERGEAU (S&D), Martin HOJSÍK (Renew), Jutta PAULUS (Greens), Anja HAZEKAMP (The Left)

Decisions in plenary, 1

Every decision Parliament took on this dossier, newest first.

**Effect**: what the decision did. **Final vote**: for–against–abstained, and how it was recorded.
Date	Decision	Kind	Effect	Final vote
16 Sept 2026	Maximum residue levels for flupyradifurone Objection under Rule 115(2), (3), and (4)(c) · implementing measure	Objections	Objection passed	383 for, 278 against, 9 abstained counted, no names

Voting grid

Export

Every roll-call vote on the dossier, in date and voting order, with each group's line at the date of the vote.

No roll-call vote was recorded on this dossier.

Add members’ columns

Versions, 1

The text of the dossier, version by version, newest first. Compare shows what changed between two consecutive versions.

Adopted by Parliament16 Sept 2026

Adopted text TA10-0295/2026 TA-10-2026-0295

Each version in short Written by AI from the official text — check the source

Adopted text TA10-0295/2026: Parliament opposes the draft Commission regulation that would raise maximum residue levels (MRLs) for flupyradifurone, including in rapeseeds from 0,3 mg/kg to 0,4 mg/kg.

Report a problem

What changed

Between consecutive versions of the text, newest pair first.

No overview of what changed between versions is available for this dossier — fewer than two versions of its text are linked in the open data.

Timeline, 2

Every recorded step, newest first, grouped by stage; the latest stage is open.

Plenary stage 1 step · 16 Sept 2026

16 September 2026

Plenary vote

Sitting of 16 Sept 2026 Motion for a resolution B10-0392/2026 Adopted text TA10-0295/2026

Committee stage 1 step · 16 Sept 2026

16 September 2026

Referred to the ENVI (Environment, Climate and Food Safety) committee

The lead committee prepares Parliament’s report.

Connections

Texts, decisions, people and other dossiers related to this one.

Texts voted on

Text MOTION FOR A RESOLUTION on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products Motion for a resolution B10-0392/2026 16 Sept 2026

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/dossiers/2026-2838
Official source: Procedure file (Legislative Observatory, OEIL)
Data source: EP Open Data API: procedure record
Licensed CC BY 4.0.
Retrieved: 25 September 2026

Cite as

European Parliament (2026). “Commission Regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products”. Dossier, 16 September 2026. procId 2026-2838, reference 2026/2838(RPS). EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/dossiers/2026-2838 (retrieved 25 September 2026). Official source: Procedure file (Legislative Observatory, OEIL), https://oeil.secure.europarl.europa.eu/oeil/en/procedure-file?reference=2026%2F2838(RPS). Data: EP Open Data API: procedure record, https://data.europarl.europa.eu/api/v2/procedures/2026-2838 (CC BY 4.0).

BibTeX

@misc{epw-dossier-2026-2838,
  author = {{European Parliament}},
  title = {{Commission Regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products}},
  year = {2026},
  date = {2026-09-16},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/dossiers/2026-2838}},
  url = {https://news.eu-parl.st-solutions.dev/dossiers/2026-2838},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Dossier. procId 2026-2838, reference 2026/2838(RPS). Official source: https://oeil.secure.europarl.europa.eu/oeil/en/procedure-file?reference=2026\%2F2838(RPS). Data: EP Open Data API: procedure record (CC BY 4.0)}
}